These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
414 related articles for article (PubMed ID: 28064239)
1. Recurrent somatic mutations affecting B-cell receptor signaling pathway genes in follicular lymphoma. Krysiak K; Gomez F; White BS; Matlock M; Miller CA; Trani L; Fronick CC; Fulton RS; Kreisel F; Cashen AF; Carson KR; Berrien-Elliott MM; Bartlett NL; Griffith M; Griffith OL; Fehniger TA Blood; 2017 Jan; 129(4):473-483. PubMed ID: 28064239 [TBL] [Abstract][Full Text] [Related]
2. Distinct patterns of B-cell receptor signaling in non-Hodgkin lymphomas identified by single-cell profiling. Myklebust JH; Brody J; Kohrt HE; Kolstad A; Czerwinski DK; Wälchli S; Green MR; Trøen G; Liestøl K; Beiske K; Houot R; Delabie J; Alizadeh AA; Irish JM; Levy R Blood; 2017 Feb; 129(6):759-770. PubMed ID: 28011673 [TBL] [Abstract][Full Text] [Related]
3. Mutations in linker histone genes HIST1H1 B, C, D, and E; OCT2 (POU2F2); IRF8; and ARID1A underlying the pathogenesis of follicular lymphoma. Li H; Kaminski MS; Li Y; Yildiz M; Ouillette P; Jones S; Fox H; Jacobi K; Saiya-Cork K; Bixby D; Lebovic D; Roulston D; Shedden K; Sabel M; Marentette L; Cimmino V; Chang AE; Malek SN Blood; 2014 Mar; 123(10):1487-98. PubMed ID: 24435047 [TBL] [Abstract][Full Text] [Related]
4. Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma. Okosun J; Bödör C; Wang J; Araf S; Yang CY; Pan C; Boller S; Cittaro D; Bozek M; Iqbal S; Matthews J; Wrench D; Marzec J; Tawana K; Popov N; O'Riain C; O'Shea D; Carlotti E; Davies A; Lawrie CH; Matolcsy A; Calaminici M; Norton A; Byers RJ; Mein C; Stupka E; Lister TA; Lenz G; Montoto S; Gribben JG; Fan Y; Grosschedl R; Chelala C; Fitzgibbon J Nat Genet; 2014 Feb; 46(2):176-181. PubMed ID: 24362818 [TBL] [Abstract][Full Text] [Related]
5. Follicular lymphoma-associated mutations in vacuolar ATPase ATP6V1B2 activate autophagic flux and mTOR. Wang F; Gatica D; Ying ZX; Peterson LF; Kim P; Bernard D; Saiya-Cork K; Wang S; Kaminski MS; Chang AE; Phillips T; Klionsky DJ; Malek SN J Clin Invest; 2019 Mar; 129(4):1626-1640. PubMed ID: 30720463 [TBL] [Abstract][Full Text] [Related]
6. The mutational landscape of ocular marginal zone lymphoma identifies frequent alterations in TNFAIP3 followed by mutations in TBL1XR1 and CREBBP. Jung H; Yoo HY; Lee SH; Shin S; Kim SC; Lee S; Joung JG; Nam JY; Ryu D; Yun JW; Choi JK; Ghosh A; Kim KK; Kim SJ; Kim WS; Park WY; Ko YH Oncotarget; 2017 Mar; 8(10):17038-17049. PubMed ID: 28152507 [TBL] [Abstract][Full Text] [Related]
7. Pan-HDAC Inhibitors Restore PRDM1 Response to IL21 in CREBBP-Mutated Follicular Lymphoma. Desmots F; Roussel M; Pangault C; Llamas-Gutierrez F; Pastoret C; Guiheneuf E; Le Priol J; Camara-Clayette V; Caron G; Henry C; Belaud-Rotureau MA; Godmer P; Lamy T; Jardin F; Tarte K; Ribrag V; Fest T Clin Cancer Res; 2019 Jan; 25(2):735-746. PubMed ID: 30348636 [TBL] [Abstract][Full Text] [Related]
8. B-cell receptor signalling and its crosstalk with other pathways in normal and malignant cells. Seda V; Mraz M Eur J Haematol; 2015 Mar; 94(3):193-205. PubMed ID: 25080849 [TBL] [Abstract][Full Text] [Related]
9. New concepts in follicular lymphoma biology: From BCL2 to epigenetic regulators and non-coding RNAs. Devan J; Janikova A; Mraz M Semin Oncol; 2018 Oct; 45(5-6):291-302. PubMed ID: 30360879 [TBL] [Abstract][Full Text] [Related]